Home/Filings/4/0001104659-25-080266
4//SEC Filing

Bendheim Daniel M 4

Accession 0001104659-25-080266

CIK 0001069899other

Filed

Aug 18, 8:00 PM ET

Accepted

Aug 19, 4:17 PM ET

Size

14.5 KB

Accession

0001104659-25-080266

Insider Transaction Report

Form 4
Period: 2025-08-15
Bendheim Daniel M
DirectorExec. VP, Corporate Strategy
Transactions
  • Award

    Class A Common Stock

    2025-08-15+3,9643,964 total
Footnotes (2)
  • [F1]The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of Class A Common Stock.
  • [F2]The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2025, subject to the Reporting Person's continued employment through the applicable vesting date.

Issuer

PHIBRO ANIMAL HEALTH CORP

CIK 0001069899

Entity typeother

Related Parties

1
  • filerCIK 0001601576

Filing Metadata

Form type
4
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 4:17 PM ET
Size
14.5 KB